Femtogenix is a biotechnology company developing DNA-interactive payload molecules for use in the antibody-drug conjugate. It provides a development platform designing molecules capable of binding reversibly and/or irreversibly to DNA, in a sequence-interactive manner, leading to exquisite cytotoxicity toward tumor cells.